Evidence map›Paper›PMID 27712627›Full record

ReviewAdvances in virus research2016

Coronavirus Spike Protein and Tropism Changes.

R J G Hulswit, C A M de Haan, B-J Bosch

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Advances in virus research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04349592 (Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19), which is not on this map. Cited by 287 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
287citing papers in PubMed, 2 pooled it
40.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04349592 nacompletednot on this mapstarted 2020, after this paper: background citation

Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

TypeinterventionalSponsorHamad Medical CorporationRan2020 to 2020Enrolled456ConditionsCovid19ArmsHydroxychloroquine, Azithromycin, Placebo Tablet, Placebo capsules
3 · Its place in the literature

Who cites it

287 citing papers in PubMed, 2 syntheses or guidelines pooled it, 483 citations in OpenAlex.

  1. Pooled it
  2. Epidemiology and Etiopathogeny of COVID-19.Advances in experimental medicine and biology · 2021
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Host Glycan-Lectin Interplay in SARS-CoV-2 Infection.International journal of molecular sciences · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

227 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R J G HulswitFaculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
C A M de HaanFaculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. Electronic address: c.a.m.dehaan@uu.nl.
B-J BoschFaculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. Electronic address: b.j.bosch@uu.nl.
Utrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronaviruses (CoVs) have a remarkable potential to change tropism. This is particularly illustrated over the last 15 years by the emergence of two zoonotic CoVs, the severe acute respiratory syndrome (SARS)- and Middle East respiratory syndrome (MERS)-CoV. Due to their inherent genetic variability, it is inevitable that new cross-species transmission events of these enveloped, positive-stranded RNA viruses will occur. Research into these medical and veterinary important pathogens-sparked by the SARS and MERS outbreaks-revealed important principles of inter- and intraspecies tropism changes. The primary determinant of CoV tropism is the viral spike (S) entry protein. Trimers of the S glycoproteins on the virion surface accommodate binding to a cell surface receptor and fusion of the viral and cellular membrane. Recently, high-resolution structures of two CoV S proteins have been elucidated by single-particle cryo-electron microscopy. Using this new structural insight, we review the changes in the S protein that relate to changes in virus tropism. Different concepts underlie these tropism changes at the cellular, tissue, and host species level, including the promiscuity or adaptability of S proteins to orthologous receptors, alterations in the proteolytic cleavage activation as well as changes in the S protein metastability. A thorough understanding of the key role of the S protein in CoV entry is critical to further our understanding of virus cross-species transmission and pathogenesis and for development of intervention strategies.

Indexed as

Viral TropismAnimalsGene ExpressionGenetic VariationHumansMiddle East Respiratory Syndrome CoronavirusModels, MolecularProtein ConformationProtein DomainsProtein SubunitsProteolysisReceptors, VirusSevere acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusVirionVirus InternalizationProtein SubunitsReceptors, VirusSpike Glycoprotein, CoronavirusCoronavirus spikeCross-species transmissionCryo-EM structureMembrane fusionReceptor interactionTropism

Identifiers

PMID27712627
PMCPMC7112277
OpenAlexW2528687767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.